Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at 8th Annual BIO Investor Forum

BUFFALO, NY--(Marketwire - October 19, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2009 BIO Investor Forum, October 28-29, in San...
October 06, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Department of Defense Increases Ongoing Contract With Cleveland BioLabs for Developmental Studies Related to Protectan CBLB502

BUFFALO, NY--(Marketwire - October 6, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Chemical Biological Medical Systems Medical Identification and Treatment Systems Joint...
October 05, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Rodman & Renshaw Initiates Analyst Coverage of Cleveland BioLabs

BUFFALO, NY--(Marketwire - October 5, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced today that Simos Simeonidis, Ph.D., Senior Biotechnology Analyst at Rodman & Renshaw, LLC, has...
September 30, 2009 11:38 ET | Source: Cleveland BioLabs, Inc.

Armed Forces Radiobiology Research Institute and Cleveland BioLabs Awarded Grant From Department of Defense to Study Radioprotective Effects of Protectan CBLB600 Series

BUFFALO, NY--(Marketwire - September 30, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Joint Science and Technology Office for Chemical and Biological Defense at the Defense...
September 29, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Awarded $5.3 Million Grand Opportunities Grant From National Institutes of Health for Protectan CBLB502 Research in Mitigation of Radiation Damage of GI Tract

BUFFALO, NY--(Marketwire - September 29, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has been awarded a $5.3 million Grand Opportunities (GO) grant under the American...
September 24, 2009 09:55 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Receives $2.3 Million Addition to $13.3 Million Contract With Biomedical Advanced Research and Development Authority (BARDA) to Develop Radiation Countermeasure Protectan CBLB502

BUFFALO, NY--(Marketwire - September 24, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Biomedical Advanced Research and Development Authority (BARDA) of the Department of...
September 22, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Additional Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage

BUFFALO, NY--(Marketwire - September 22, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has been awarded an additional $458,512 grant from the National Institute of Allergy...
September 21, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at Maxim Group Growth Conference

BUFFALO, NY--(Marketwire - September 21, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Maxim Group Growth Conference, September 29, in...
September 09, 2009 09:36 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs and Zhejiang Hisun Pharmaceutical Enter License Agreement for Protectan CBLB612 Hematopoietic Stem Cell Stimulator and Mobilizer in China

BUFFALO, NY--(Marketwire - September 9, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Zhejiang Hisun Pharmaceutical Co. Ltd. (SHSE: 600267), a leading pharmaceutical manufacturer in the People's...
September 08, 2009 08:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at NewsMakers in the Biotech Industry Conference

BUFFALO, NY--(Marketwire - September 8, 2009) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 16th Annual NewsMakers in the Biotech Industry...